Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study : a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160)

• OGAWA Hisao

  Department of Cardiovascular Medicine, Kumamoto University Graduate School of Medical Sciences

• KIM MITSUYAMA Shokei

  Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences

• JINNOUCHI Tomio

  Jinnouchi Clinic, Diabetes Care Center

• MATSUI Kunihiko

  Clinical Education Center, Kumamoto University Hospital

• ARAKAWA Kikuo

  The Second Department of Internal Medicine, School of Medicine, Fukuoka University

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 32 (7), 575-580, 2009-07-01

キーワード

• combination of ARB with CCB
• elderly high-risk hypertension
• high-dose ARB
• olmesartan medoxomil

詳細情報

• CRID: 1571135650845403392
• NII論文ID: 10025164113
• NII書誌ID: AA10847079
• ISSN: 09169636
• 本文言語コード: en
• データソース種別:
  • CiNii Articles